MARKET

SRNE

SRNE

Sorrento Therapeutics Inc
EXMKT
0.0035
-0.0015
-30.00%
Closed 15:55 10/11 EDT
OPEN
0.0028
PREV CLOSE
0.0050
HIGH
0.0050
LOW
0.0028
VOLUME
313.58K
TURNOVER
1.17K
52 WEEK HIGH
0.419
52 WEEK LOW
0.0002
MARKET CAP
1.65M
P/E (TTM)
-0.0032
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SRNE last week (0930-1004)?
Weekly Report · 4d ago
Weekly Report: what happened at SRNE last week (0923-0927)?
Weekly Report · 09/30 11:13
Weekly Report: what happened at SRNE last week (0916-0920)?
Weekly Report · 09/23 11:12
Weekly Report: what happened at SRNE last week (0909-0913)?
Weekly Report · 09/16 11:03
Weekly Report: what happened at SRNE last week (0902-0906)?
Weekly Report · 09/09 11:13
Weekly Report: what happened at SRNE last week (0826-0830)?
Weekly Report · 09/02 11:16
Weekly Report: what happened at SRNE last week (0819-0823)?
Weekly Report · 08/26 11:14
Healthcare bankruptcies slow after peaking in 2023: report
Seeking Alpha · 08/24 15:25
More
About SRNE
Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next-generation of cancer therapeutics. The Scilex segment is organized around its non-opioid pain management operations and clinical pipeline. The Company’s immuno-oncology platforms, including its fully human antibodies (G-MAB library), ACEA small molecule library, immuno-cellular therapies (DAR-T), antibody-drug conjugates (ADCs) and oncolytic virus (Seprehvec). The Company is also developing potential antiviral therapies against COVID-19, including FUJOVEE (Abivertinib) and its rapid diagnostic test, including COVIMARK.

Webull offers Sorrento Therapeutics Inc stock information, including EXMKT: SRNE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRNE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRNE stock methods without spending real money on the virtual paper trading platform.